期刊文献+

红细胞免疫指标与T淋巴细胞亚群及免疫球蛋白水平在慢性HBV感染中的价值研究 被引量:19

Detection values of erythrocyte immunity index,T lymphocyte subsets and immunoglobulin levels in patients with chronic HBV infection
原文传递
导出
摘要 目的探讨红细胞免疫指标、T淋巴细胞亚群及免疫球蛋白水平在慢性乙型肝炎病毒(HBV)感染检测中的价值,为临床治疗提供参考依据。方法 2015年5月-2016年5月分别采用郭氏法、流式细胞术和免疫散射法检测224例HBV感染患者全血标本,其中慢性乙型肝炎组患者126例和肝硬化组患者98例,选取同期健康体检者102例为对照组,比较3组红细胞免疫指标。结果各组红细胞免疫指标、T淋巴细胞亚群及免疫球蛋白水平比较,差异均有统计学意义(P<0.05);logistic回归模型分析,RBC-C3bR、RBC-ICR、IgG的危险度分别为5.34、5.16、4.56,可作为肝硬化发生的独立危险因素。结论在HBV感染、慢性乙型肝炎、肝硬化的发展过程中存在红细胞免疫、T淋巴细胞亚群及免疫球蛋白的改变,其中RBC-C3bR、RFER、IgG指标的变化与肝硬化发生密切相关。 OBJECTIVE To discuss the values of erythrocyte immunity index,T lymphocyte subsets and immunoglobulin levels in patients with chronic hepatitis B virus(HBV)infection detection,so as to provide references for clinical treatment.METHODS From May 2015 to May 2016,whole blood specimens of 224 cases of HBV infection patients were detected by Kuok,flow cytometry and immunohistochemistry scattering method,of which chronic hepatitis B infection group with 126 cases and cirrhosis group with 98 cases,and 102 cases of healthy volunteers during the same period were set as control group.The erythrocyte immunity indexes were compared.RESULTS There were significant differences in erythrocyte immunity indexes,T lymphocyte subsets and immunoglobulin levels among different groups(P〈0.05).Logistic regression analysis showed that the risks of RBC-C3 bR,RBCICR and IgG were 5.34,5.16 and 4.56,respectively,which could be used as independent risk factors for cirrhosis.CONCLUSIONErythrocyte immunity indexes,T lymphocyte subsets and immunoglobulin levels are changing in the development of HBV infection,chronic hepatitis and cirrhosis,of which RBC-C3 bR,RBC-ICR and IgG are closely related to for cirrhosis.
作者 鲁晓娟 王娟 白莹立 闫灿 LU Xiao-juan WANG Juan BAI Ying-li YAN Can(Zhengzhou Railway Vocational and Technical College, Zhengzhou, Henan 451460, China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第23期5351-5353,共3页 Chinese Journal of Nosocomiology
基金 河南省教育厅科学技术研究重点项目(142202363144)
关键词 红细胞免疫指标 T淋巴细胞亚群 免疫球蛋白 乙型肝炎病毒 Erythrocyte immunity index T lymphocyte subsets Immunoglobulin Hepatitis B virus
  • 相关文献

参考文献4

二级参考文献51

  • 1European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection[J]. Journal of Hepatology . 2012 (1)
  • 2D.J.W. Wesdorp,M. Knoester,A.E. Braat,M.J. Coenraad,A.C.T.M. Vossen,E.C.J. Claas,B. van Hoek.Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective[J]. Journal of Clinical Virology . 2013
  • 3Yeo W,Chan PK,Zhong S,et al.Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. Journal of Medical Virology . 2000
  • 4Yi-Hsiang Huang,Liang-Tsai Hsiao,Ying-Chung Hong,Tzeon-Jye Chiou,Yuan-Bin Yu,Jyh-Pyng Gau,Chun-Yu Liu,Muh-Hwa Yang,Cheng-Hwai Tzeng,Pui-Ching Lee,Han-Chieh Lin,Shou-Dong Lee.Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B[J].Journal of Clinical Oncology.2013(22)
  • 5Chien-Hung Chen,Chih-Lang Lin,Tsung-Hui Hu,Chao-Hung Hung,Po-Lin Tseng,Jing-Houng Wang,Juan-Yu Chang,Sheng-Nan Lu,Rong-Nan Chien,Chuan-Mo Lee.Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation[J].Journal of Hepatology.2014
  • 6Kitagishi Y,Kobayashi M,Yamashina Y,et al. Elucidating theregulation of T cell subsets(review)[J].Int J Mol Med,2012,30(6): 1255.
  • 7Ma SW, Huang X, Li YY, et al. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B[J]. J Hepatol, 2012, 56(4): 775-781.
  • 8Lobaina Y, Hardtke S, Wedemeyer H, et al. In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors[J]. Mol Immunol, 2015, 63(2): 320-327.
  • 9J.‐H. Cho,J.‐H. Lim,G.‐Y. Park,J.‐S. Kim,Y.‐J. Kang,O. Kwon,J.‐Y. Choi,S.‐H. Park,Y.‐L. Kim,H.‐K. Kim,S. Huh,C.‐D. Kim.Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection[J]. Transpl Infect Dis . 2014 (2)
  • 10C. Pipili,E. Cholongitas,G. Papatheodoridis.Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease[J]. Aliment Pharmacol Ther . 2014 (1)

共引文献26

同被引文献163

引证文献19

二级引证文献178

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部